Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluorine 18 LBT 999 - Zionexa

Next Previous
Drug Profile

Fluorine 18 LBT 999 - Zionexa

Alternative Names: [18F]-LBT-999-PET; [18F]-LBT999; LBT-999; LBT-999-PET; LBT999-[18F]

Latest Information Update: 22 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cyclopharma; INSERM; University of Tours
  • Developer Zionexa
  • Class Alkenes; Diagnostic agents; Esters; Fluorinated hydrocarbons; Imaging agents; Radiopharmaceutical diagnostics; Toluenes; Tropanes
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Parkinson's disease
  • Phase II Coma

Most Recent Events

  • 14 Jan 2025 Phase-II clinical trials in Coma (Diagnosis) in France (unspecified route) (NCT06930261)
  • 26 Jul 2022 Fluorine 18 LBT 999 is still in phase III trials for Parkinson's disease in France (NCT04265209)
  • 06 May 2021 Zionexa has been acquired by GE Healthcare

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top